EvidenceCare Announces Close of Series A from Jumpstart Capital

Dave Vreeland, Managing Director of Jumpstart Capital, will be joining EvidenceCare’s Board of Directors following JSC’s major investment in the company. EvidenceCare, a Nashville-based healthcare tech firm, closed its Series A round of funding after receiving an additional strategic investment from Jumpstart Capital. JSC looks forward to leveraging its network power to accelerate sales efforts into major health systems across the U.S.

For the full article, view the press release below.


Q3 has been filled with good fortune for Jumpstart Capital. In our quarterly installment, we share the latest results in our efforts to round out the Fund while simultaneously deploying capital into multiple disruptive companies.

We’re delighted that the Fund is ~65% subscribed and right on schedule. Learn more in this update about how several significant partnership opportunities may take us beyond expectations in Q4.

We’ve taken positions in two additional companies: SimplifyASC is a cloud-based clinical and practice management software solution for the underserved ambulatory surgery center (ASC) market. We led the Series A, joined the board, and are hands-on supporting the success of this innovative Nashville-based company. We also joined other world-class investors in a Series C round for higi, based in Chicago. Higi has 11,000 health ‘stations’ nationwide in well-known retail pharmacies and they’re creating a new ‘front door’ for primary care—a true population health enablement solution with a terrific opportunity to help millions of people. We hope you’ll echo our enthusiasm when you read more about SimplifyASC and higi below.

Highlights from the 2018 Health:Further event along with major events in the healthcare provider, payer, and consumer markets in the last three months have made us more bullish on our investment thesis than ever. Inside, you’ll learn more about the continued developments of strange bedfellows in the healthcare landscape and the rising empowerment of the consumer as decision-maker. We thank each of you for taking this journey with us.

SimplifyASC Appoints Scott Kolesar to Board of Directors

The Jumpstart Capital team is excited about the official appointment of Scott Kolesar to SimplifyASC’s Board of Directors. Mr. Kolesar is an experienced health tech executive who will bring deep industry knowledge to the SimplifyASC board. SimplifyASC is looking forward to the new appointment for, “It’s not often leaders of Scott’s caliber commit to serve early-stage growth companies...” CEO, David Howerton said.

Previously known as 'CyramedX,' SimplifyASC also released a new brand, logo, and splash page. The Jumpstart Capital team is looking forward to what lies ahead for SimplifyASC.


Jumpstart Capital Makes Series A Investment in SimplifyASC

The Jumpstart Capital team is proud to announce a Series A investment in SimplifyASC, a developer of EHR and practice management solutions for ambulatory surgery centers (ASCs). SImplifyASC's software platform exponentially accelerates an organization's operational efficiency and data management. SimplifyASC is the new name for the company. Formerly CyramedX, the team will be rolling out new branding, logo and website content in the coming weeks. 

The Jumpstart Capital team is impressed with SimplifyASC's strong vision and team. We expect this investment from Jumpstart Capital to accelerate SimplifyASC's market penetration, and revolutionize the ASC marketplace. 

Backing Away from the Abyss: How Technology, Demographics and Consumer Demand Will Save the U.S. Healthcare System

Jumpstart Capital's Managing Director Dave Vreeland's recently-published annual take on the current status of the U.S. Healthcare System and his view on the changes coming in the next 15-20 years is riveting. Dave takes a macroeconomic, macro-demographic, and geopolitical view of the forces impacting healthcare during the next two decades.

Take a closer look for Dave's views on these important issues in "Backing Away from the Abyss: How Technology, Demographics and Consumer Demand Will Save the U.S. Healthcare System."


Jumpstart Capital has seen a full and exciting couple of months. Quarter 2 has been focused on fund raising with prospective opportunities for investment as we are more than halfway to our $30MM mark and approaching our second capital call on June 29. Our five portfolio companies, Healthy Bytes, Reemo, Life Detection Technologies, Menud, and Pillsy have been progressing well and executing partnerships, deals, and distribution opportunities.

In early May, two of our portfolio companies, Pillsy and Menud, had the opportunity to pitch during ‘Demo Day’ at the ‘Retail Tomorrow Executive Innovation Series’ in Seattle. We learned about Amazon’s business strategies and how we can utilize them for the healthcare industry. We have successfully implemented Carta, our transparent investment tracking system, and established a line of credit collateralized against committed capital.


This newsletter will expand upon our portfolio’s progress and what we are forecasting for the next quarter.

Jumpstart Foundry’s Healthcare Portfolio Reaches 60+ with 2018 Investments

Our seed fund business, Jumpstart Foundry, just closed its 2018 cohort of innovative healthcare companies. These businesses form the basis for Jumpstart Capital's future deal flow. Jumpstart Capital could not be more excited about these great founders and businesses. We look forward to watching them grow. Congratulations to the Jumpstart Foundry team and its Managing Director Eller Mallchok

Q1 2018: Investment Updates, Healthcare Market Review, Data Trends & More.

The past few months proved to be a successful and busy time for the folks here at Jumpstart Capital. We entered Q1 following a largely successful first close of the Growth Fund, with raises for Reemo Health, Sightbox, and Life Detection Technologies. As we approach our second close later this month, we expect to reach more than half of our fund's $30M goal committed. 

We wanted to take the time to share more about what the Jumpstart Capital team has been up to: In this newsletter, you'll find updates on our portfolio company investments, partnerships, and due diligence. You'll also find our review and analysis of the healthcare innovation landscape: from Fast Company's Report on Retail to PwC's Top Industry Issues of 2018, to Raymond Jame's 2018 Equity Market Outlook.



Interested in learning more about what we're up to at Jumpstart Capital? Get in touch.